Evidence map›Paper›PMID 22262002›Full record

ReviewCurrent opinion in endocrinology, diabetes, and obesity2012

Type 2 diabetes and bone fractures.

Kendall F Moseley

Open access · greenAbstract readReview
In one paragraph

Review in Current opinion in endocrinology, diabetes, and obesity, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 74 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
74citing papers in PubMed, 2 pooled it
5.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

74 citing papers in PubMed, 2 syntheses or guidelines pooled it, 135 citations in OpenAlex.

  1. Risk of low-energy fracture in type 2 diabetes patients: a meta-analysis of observational studies.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2017
    Pooled it
  2. Association between sleep apnea and low bone mass in adults: a systematic review and meta-analysis.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2017
    Pooled it
  3. Trial
  4. Review
  5. Exploring multiple drug actions of a CaNaunyn-Schmiedeberg's archives of pharmacology · 2026
    Review
  6. Article
  7. Article
  8. Skeletal Health in Youth with Type 2 Diabetes.Current osteoporosis reports · 2025
    Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article

14 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Kendall F MoseleyDivision of Endocrinology, Johns Hopkins Bayview Medical Center, Baltimore, Maryland, USA. kmosele4@jhmi.edu
Johns Hopkins Bayview Medical Center · US

Funding

Defining and demystifying bone quality in type 2 diabetes mellitusK23DK093720 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI MOSELEY, KENDALL · 2012 to 2016
$924k
Glycemic derangement and osteogenic cells:A model of Premature skeletal agingR03AG040695 · NIA · JOHNS HOPKINS UNIVERSITY · PI MOSELEY, KENDALL · 2011 to 2012
$162k
NIA NIH HHS 1R03AG040695-01NIA NIH HHS R03 AG040695NIDDK NIH HHS K23 DK093720
6 · The paper itself

Abstract

purpose of reviewTo discuss current literature and hypotheses pertaining to the pathophysiology of increased bone fragility and fracture in men and women with type 2 diabetes mellitus. RECENT

findingsDespite high bone mineral density, studies have shown that men and women with type 2 diabetes mellitus (T2DM) are at increased risk for fracture. Complications of T2DM including retinopathy and autonomic dysfunction may contribute to bone fracture by increasing fall risk. Nephropathy may lead to renal osteodystrophy. Lean mass and potentially fat mass, may additionally contribute to skeletal health in diabetes. There is increasing acknowledgement that the marrow microenvironment is critical to efficient bone remodeling. Medications including thiazolidinediones and selective serotonin reuptake inhibitors may also impair bone remodeling by acting on mesenchymal stem cell differentiation and osteoblastogenesis. T2DM is associated with significant alterations in systemic inflammation, advanced glycation end-product accumulation and reactive oxygen species generation. These systemic changes may also directly and adversely impact the remodeling cycle and lead to bone fragility in T2DM, though more research is needed. SUMMARY: Fracture is a devastating event with dismal health consequences. Identifying the extrinsic and intrinsic biochemical causes of bone fracture in T2DM will speed the discovery of effective strategies for fracture prevention and treatment in this at-risk population.

Indexed as

Accidental FallsAdultAgedAged, 80 and overAutonomic Nervous System DiseasesBody Mass IndexBone DensityBone RemodelingChronic Kidney Disease-Mineral and Bone DisorderDiabetes Mellitus, Type 2Diabetic NephropathiesFemaleFractures, BoneHumansHypoglycemic AgentsMaleHypoglycemic AgentsThiazolidinediones

Identifiers

PMID22262002
PMCPMC4753802
OpenAlexW2096187668

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.